• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究膜转运蛋白的生物学和药理学的化学方法:以组氨酸/大氨基酸转运蛋白 SLC7A5 为基准。

Chemical Approaches for Studying the Biology and Pharmacology of Membrane Transporters: The Histidine/Large Amino Acid Transporter SLC7A5 as a Benchmark.

机构信息

Unit of Biochemistry and Molecular Biotechnology, Department DiBEST (Biologia, Ecologia, Scienze della Terra), University of Calabria, Via P. Bucci 4C, 87036 Arcavacata di Rende, Italy.

CNR Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council, Via Orabona 4, 70126 Bari, Italy.

出版信息

Molecules. 2021 Oct 29;26(21):6562. doi: 10.3390/molecules26216562.

DOI:10.3390/molecules26216562
PMID:34770970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8588388/
Abstract

The localization of membrane transporters at the forefront of natural barriers makes these proteins very interesting due to their involvement in the absorption and distribution of nutrients and xenobiotics, including drugs. Over the years, structure/function relationship studies have been performed employing several strategies, including chemical modification of exposed amino acid residues. These approaches are very meaningful when applied to membrane transporters, given that these proteins are characterized by both hydrophobic and hydrophilic domains with a different degree of accessibility to employed chemicals. Besides basic features, the chemical targeting approaches can disclose information useful for pharmacological applications as well. An eminent example of this picture is the histidine/large amino acid transporter SLC7A5, known as LAT1 (Large Amino Acid Transporter 1). This protein is crucial in cell life because it is responsible for mediating the absorption and distribution of essential amino acids in peculiar body districts, such as the blood brain barrier and placenta. Furthermore, LAT1 can recognize a large variety of molecules of pharmacological interest and is also considered a hot target for drugs due to its over-expression in virtually all human cancers. Therefore, it is not surprising that the chemical targeting approach, coupled with bioinformatics, site-directed mutagenesis and transport assays, proved fundamental in describing features of LAT1 such as the substrate binding site, regulatory domains and interactions with drugs that will be discussed in this review. The results on LAT1 can be considered to have general applicability to other transporters linked with human diseases.

摘要

膜转运蛋白定位于天然屏障的前沿,由于其参与营养物质和外源性物质(包括药物)的吸收和分布,因此这些蛋白质非常有趣。多年来,已经采用了几种策略(包括暴露的氨基酸残基的化学修饰)来进行结构/功能关系研究。鉴于这些蛋白质具有不同程度的疏水性和亲水性区域,并且对所使用的化学物质具有不同的可及性,因此这些方法对于膜转运蛋白非常有意义。除了基本特征外,化学靶向方法还可以揭示对药理学应用有用的信息。这种情况的一个突出例子是组氨酸/大氨基酸转运蛋白 SLC7A5,称为 LAT1(大氨基酸转运蛋白 1)。该蛋白在细胞生命中至关重要,因为它负责介导必需氨基酸在特殊身体区域(如血脑屏障和胎盘)中的吸收和分布。此外,LAT1 可以识别多种具有药理兴趣的分子,并且由于其在几乎所有人类癌症中的过度表达,也被认为是药物的热门靶标。因此,化学靶向方法与生物信息学、定点诱变和转运测定相结合,对描述 LAT1 的特征(如底物结合位点、调节域以及与药物的相互作用)至关重要,这并不奇怪。本综述将讨论这些结果。关于 LAT1 的结果可以被认为具有普遍适用性,可以应用于与人类疾病相关的其他转运蛋白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a3/8588388/eef365dd6b2c/molecules-26-06562-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a3/8588388/f1deb09f8c6d/molecules-26-06562-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a3/8588388/eef365dd6b2c/molecules-26-06562-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a3/8588388/f1deb09f8c6d/molecules-26-06562-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a3/8588388/eef365dd6b2c/molecules-26-06562-g002.jpg

相似文献

1
Chemical Approaches for Studying the Biology and Pharmacology of Membrane Transporters: The Histidine/Large Amino Acid Transporter SLC7A5 as a Benchmark.研究膜转运蛋白的生物学和药理学的化学方法:以组氨酸/大氨基酸转运蛋白 SLC7A5 为基准。
Molecules. 2021 Oct 29;26(21):6562. doi: 10.3390/molecules26216562.
2
The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health.人类溶质载体家族7成员5(LAT1):引人入胜的组氨酸/大型中性氨基酸转运体及其与人类健康的关联。
Front Chem. 2018 Jun 22;6:243. doi: 10.3389/fchem.2018.00243. eCollection 2018.
3
Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation.深入了解人氨基酸转运蛋白 LAT1(SLC7A5)的转运机制。探究底物转运的关键残基。
Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):727-736. doi: 10.1016/j.bbagen.2017.01.013. Epub 2017 Jan 11.
4
Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics.氨基酸转运蛋白 LAT1(SLC7A5)作为癌症诊断和治疗的分子靶标。
Pharmacol Ther. 2022 Feb;230:107964. doi: 10.1016/j.pharmthera.2021.107964. Epub 2021 Aug 12.
5
The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.重链 4F2hc 调节轻链 LAT1 和 LAT2 的底物亲和力和特异性。
Int J Mol Sci. 2020 Oct 14;21(20):7573. doi: 10.3390/ijms21207573.
6
The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.L 型氨基酸转运蛋白 1(LAT1)在癌症中的作用。
Curr Cancer Drug Targets. 2019;19(11):863-876. doi: 10.2174/1568009619666190802135714.
7
The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).谷氨酰胺转运蛋白 ASCT2(SLC1A5)独立于氨基酸转运蛋白 LAT1(SLC7A5)促进肿瘤生长。
J Biol Chem. 2018 Feb 23;293(8):2877-2887. doi: 10.1074/jbc.RA117.001342. Epub 2018 Jan 11.
8
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).重新评估 L 型氨基酸转运体(LAT1)的底物特异性。
J Med Chem. 2018 Aug 23;61(16):7358-7373. doi: 10.1021/acs.jmedchem.8b01007. Epub 2018 Aug 10.
9
Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol.通过膜胆固醇调节 LAT1(SLC7A5)转运体的活性和稳定性。
Sci Rep. 2017 Mar 8;7:43580. doi: 10.1038/srep43580.
10
Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.培高利特经 L 型氨基酸转运蛋白 1(SLC7A5)在人脑微血管内皮细胞系中的转运。
Pharm Res. 2018 Oct 29;35(12):246. doi: 10.1007/s11095-018-2532-0.

引用本文的文献

1
L‑type amino acid transporter 1 in enhancing boron neutron capture therapy: Mechanisms, challenges and future directions (Review).L型氨基酸转运体1在增强硼中子俘获治疗中的作用:机制、挑战与未来方向(综述)
Int J Mol Med. 2025 Nov;56(5). doi: 10.3892/ijmm.2025.5611. Epub 2025 Aug 24.
2
Involvement of mammalian SoLute Carriers (SLC) in the traffic of polyamines.哺乳动物溶质载体(SLC)在多胺转运中的作用。
Front Mol Biosci. 2024 Jul 25;11:1452184. doi: 10.3389/fmolb.2024.1452184. eCollection 2024.
3
LAT1 (SLC7A5) catalyzes copper(histidinate) transport switching from antiport to uniport mechanism.

本文引用的文献

1
Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics.氨基酸转运蛋白 LAT1(SLC7A5)作为癌症诊断和治疗的分子靶标。
Pharmacol Ther. 2022 Feb;230:107964. doi: 10.1016/j.pharmthera.2021.107964. Epub 2021 Aug 12.
2
Hemocompatible L-Type amino acid transporter 1 (LAT1)-Utilizing prodrugs of perforin inhibitors can accumulate into the pancreas and alleviate inflammation-induced apoptosis.具有血液相容性的利用L型氨基酸转运体1(LAT1)的穿孔素抑制剂前药可在胰腺中蓄积并减轻炎症诱导的细胞凋亡。
Chem Biol Interact. 2021 Aug 25;345:109560. doi: 10.1016/j.cbi.2021.109560. Epub 2021 Jun 18.
3
LAT1(溶质载体家族7成员5)催化铜(组氨酸盐)转运,其机制从反向转运转变为单向转运。
iScience. 2023 Aug 26;26(10):107738. doi: 10.1016/j.isci.2023.107738. eCollection 2023 Oct 20.
4
Characterization of substrates and inhibitors of the human heterodimeric transporter 4F2hc-LAT1 using purified protein and the scintillation proximity radioligand binding assay.利用纯化蛋白和闪烁邻近放射性配体结合试验对人异源二聚体转运蛋白4F2hc-LAT1的底物和抑制剂进行表征。
Front Physiol. 2023 Feb 21;14:1148055. doi: 10.3389/fphys.2023.1148055. eCollection 2023.
5
Insights into the Transport Cycle of LAT1 and Interaction with the Inhibitor JPH203.LAT1 转运周期的研究进展及其与抑制剂 JPH203 的相互作用
Int J Mol Sci. 2023 Feb 17;24(4):4042. doi: 10.3390/ijms24044042.
6
Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer.生物信息学预测与体内验证确定SLC7A5为乳腺癌免疫浸润相关生物标志物。
Cancer Manag Res. 2022 Aug 27;14:2545-2559. doi: 10.2147/CMAR.S370397. eCollection 2022.
7
The Nutraceutical Alliin From Garlic Is a Novel Substrate of the Essential Amino Acid Transporter LAT1 (SLC7A5).大蒜中的营养成分蒜氨酸是必需氨基酸转运体LAT1(SLC7A5)的一种新型底物。
Front Pharmacol. 2022 Mar 24;13:877576. doi: 10.3389/fphar.2022.877576. eCollection 2022.
ATP modulates SLC7A5 (LAT1) synergistically with cholesterol.
三磷酸腺苷与胆固醇协同调节溶质载体家族 7 成员 5(LAT1)。
Sci Rep. 2020 Oct 7;10(1):16738. doi: 10.1038/s41598-020-73757-y.
4
UCSF ChimeraX: Structure visualization for researchers, educators, and developers.UCSF ChimeraX:面向研究人员、教育工作者和开发者的结构可视化工具。
Protein Sci. 2021 Jan;30(1):70-82. doi: 10.1002/pro.3943. Epub 2020 Oct 22.
5
Chemical Targeting of Membrane Transporters: Insights into Structure/Function Relationships.膜转运蛋白的化学靶向:对结构/功能关系的见解
ACS Omega. 2020 Jan 28;5(5):2069-2080. doi: 10.1021/acsomega.9b04078. eCollection 2020 Feb 11.
6
A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1.通过抑制 LAT1 为间变性甲状腺癌提供一种新的治疗方法。
Sci Rep. 2019 Oct 10;9(1):14616. doi: 10.1038/s41598-019-51144-6.
7
Methionine metabolism in health and cancer: a nexus of diet and precision medicine.甲硫氨酸代谢与健康和癌症:饮食与精准医学的交汇点。
Nat Rev Cancer. 2019 Nov;19(11):625-637. doi: 10.1038/s41568-019-0187-8. Epub 2019 Sep 12.
8
Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs.利用 SLC 膜转运蛋白的半胱氨酸残基作为药物靶点。
SLAS Discov. 2019 Oct;24(9):867-881. doi: 10.1177/2472555219856601. Epub 2019 Jun 28.
9
l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan.1,2,3-三唑基 l-组氨酸和 l-色氨酸类似物的 l-型氨基酸转运蛋白 1 活性。
Bioorg Med Chem Lett. 2019 Aug 15;29(16):2254-2258. doi: 10.1016/j.bmcl.2019.06.033. Epub 2019 Jun 20.
10
Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.冷冻电镜结构解析人 L 型氨基酸转运蛋白 1 与糖蛋白 CD98hc 的复合物
Nat Struct Mol Biol. 2019 Jun;26(6):510-517. doi: 10.1038/s41594-019-0237-7. Epub 2019 Jun 3.